CytexOrtho

CytexOrtho

Growth Stage

One Biodegradable Implant. Full Joint Restoration.

One Biodegradable Implant. Full Joint Restoration.

Overview

Raised this Round: Raised: $470,596

Total Commitments ($USD)

Platform

StartEngine

Start Date

10/26/2022

Close Date

01/24/2023

Min. Goal
$10,000
Max. Goal
$1,070,000
Min. Investment

$250

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$2.00

Pre-Money Valuation

$18,183,464

Year Founded

2006

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

Low

Capital Intensity

High

Location

Durham, North Carolina

Business Type

Growth

CytexOrtho, with a valuation of $18.18 million, is raising funds on StartEngine. It is a healthcare company developing solutions to address early joint degeneration in younger patients. The lead product of CytexOrtho is a biodegradable medical implant that restores joint cartilage and bone instead of replacing them with artificial materials. The implant is made using 3D printing and 3D woven textile and mimics the functionality of healthy joint tissues. Bradley Estes, Franklin Moutos, and Farshid Guilak founded CytexOrtho in July 2006. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1.07 million. The campaign proceeds will be used to expand the hip implant indication and use and expand the product portfolio to other joints as well.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$1,836,602

$1,845,230

COGS

$1,263,476

$1,288,308

Tax

$0

$0

 

 

Net Income

$-22,653

$40,442

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$489,299

$267,208

Accounts Receivable

$66,611

$197,422

Total Assets

$626,138

$480,707

Short-Term Debt

$144,543

$233,574

Long-Term Debt

$0

$0

Total Liabilities

$144,543

$233,574

Financials as of: 10/26/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
CytexOrtho on StartEngine 2022
Platform: StartEngine
Security Type: Equity - Common
Valuation: $18,183,464
Price per Share: $2.00

Follow company

Follow CytexOrtho on StartEngine 2022

Buy CytexOrtho's Deal Report

Warning: according to the close date for this deal, CytexOrtho may no longer be accepting investments.

CytexOrtho Deal Report

Get KingsCrowd’s comprehensive report on CytexOrtho including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether CytexOrtho is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the CytexOrtho deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge